Download PDF
Semin Thromb Hemost 2011; 37(7): 756-762
DOI: 10.1055/s-0031-1297166
© Thieme Medical Publishers

Clinical and Laboratory Assessment of the Bleeding Pediatric Patient

Shoshana Revel-Vilk1
  • 1Department of Pediatric Hematology/Oncology, Hadassah Hebrew University Hospital, Jerusalem, Israel
Further Information

Publication History

Publication Date:
20 December 2011 (online)

    Permissions and Reprints

ABSTRACT

Children presenting with bleeding symptoms pose a diagnostic challenge. The evaluation should include a comprehensive medical and bleeding history, detailed family history, a physical examination, and selected laboratory tests. Evaluation of the bleeding history should include an objective quantitation of the bleeding symptoms, followed by objective quantitation of the family members' bleeding symptoms. If a bleeding disorder is suspected, based on personal and/or family bleeding history, specific laboratory testing is needed for attaining a diagnosis. The screening tests for coagulation factor deficiencies are considered reliable, routinely available, and easy to perform. However, for primary hemostatic defects, the various screening tests have not yet proven to be reliable and thus referral for a specialized hematology consultation and specific laboratory testing are needed. Perhaps a Bayes theorem approach, combining the personal and family bleeding history with the results of a screening test for a primary hemostatic defect would prove to be useful in the identification of those children who will most benefit from specific laboratory testing.

KEYWORDS

Bleeding disorder - assessment - children - bleeding questionnaires - laboratory screening

REFERENCES

  • 1 Werner E J, Broxson E H, Tucker E L, Giroux D S, Shults J, Abshire T C. Prevalence of von Willebrand disease in children: a multiethnic study.  J Pediatr. 1993;  123 (6) 893-898
    Google Scholar
  • 2 Bowman M, Hopman W M, Rapson D, Lillicrap D, James P. The prevalence of symptomatic von Willebrand disease in primary care practice.  J Thromb Haemost. 2010;  8 (1) 213-216
    Google Scholar
  • 3 Bowman M, Hopman W M, Rapson D, Lillicrap D, Silva M, James P. A prospective evaluation of the prevalence of symptomatic von Willebrand disease (VWD) in a pediatric primary care population.  Pediatr Blood Cancer. 2010;  55 (1) 171-173
    Google Scholar
  • 4 Peyvandi F, Cattaneo M, Inbal A, De Moerloose P, Spreafico M. Rare bleeding disorders.  Haemophilia. 2008;  14 (Suppl 3) 202-210
    Google Scholar
  • 5 Salles I I, Feys H B, Iserbyt B F, De Meyer S F, Vanhoorelbeke K, Deckmyn H. Inherited traits affecting platelet function.  Blood Rev. 2008;  22 (3) 155-172
    Google Scholar
  • 6 Nurden P, Nurden A T. Congenital disorders associated with platelet dysfunctions.  Thromb Haemost. 2008;  99 (2) 253-263
    Google Scholar
  • 7 Hayward C P, Rao A K, Cattaneo M. Congenital platelet disorders: overview of their mechanisms, diagnostic evaluation and treatment.  Haemophilia. 2006;  12 (Suppl 3) 128-136
    Google Scholar
  • 8 Blanchette V S, Bolton-Maggs P. Childhood immune thrombocytopenic purpura: diagnosis and management.  Pediatr Clin North Am. 2008;  55 (2) 393-420, ix
    Google Scholar
  • 9 Cines D B, Bussel J B, McMillan R B, Zehnder J L. Congenital and acquired thrombocytopenia.  Hematology (Am Soc Hematol Educ Program). 2004;  390-406
    Google Scholar
  • 10 Anwar R, Minford A, Gallivan L, Trinh C H, Markham A F. Delayed umbilical bleeding—a presenting feature for factor XIII deficiency: clinical features, genetics, and management.  Pediatrics. 2002;  109 (2) E32
    Google Scholar
  • 11 Carcao M D, Blanchette V S. Work-up of a bleeding child. In: Lee C, Berntorp E, Hoots K, eds. Textbook of Hemophilia. 2nd ed. West, Sussex, UK: Blackwell; 2010: 118-126
    Google Scholar
  • 12 Seligsohn U. Factor XI deficiency in humans.  J Thromb Haemost. 2009;  7 (Suppl 1) 84-87
    Google Scholar
  • 13 Simon D, Kunicki T, Nugent D. Platelet function defects.  Haemophilia. 2008;  14 (6) 1240-1249
    Google Scholar
  • 14 Nosek-Cenkowska B, Cheang M S, Pizzi N J, Israels E D, Gerrard J M. Bleeding/bruising symptomatology in children with and without bleeding disorders.  Thromb Haemost. 1991;  65 (3) 237-241
    Google Scholar
  • 15 Lillicrap D, Nair S C, Srivastava A, Rodeghiero F, Pabinger I, Federici A B. Laboratory issues in bleeding disorders.  Haemophilia. 2006;  12 (Suppl 3) 68-75
    Google Scholar
  • 16 Rodeghiero F, Kadir R A, Tosetto A, James P D. Relevance of quantitative assessment of bleeding in haemorrhagic disorders.  Haemophilia. 2008;  14 (Suppl 3) 68-75
    Google Scholar
  • 17 Rodeghiero F, Castaman G, Tosetto A et al.. The discriminant power of bleeding history for the diagnosis of type 1 von Willebrand disease: an international, multicenter study.  J Thromb Haemost. 2005;  3 (12) 2619-2626
    Google Scholar
  • 18 Tosetto A, Rodeghiero F, Castaman G et al.. A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD).  J Thromb Haemost. 2006;  4 (4) 766-773
    Google Scholar
  • 19 Bowman M, Riddel J, Rand M L, Tosetto A, Silva M, James P D. Evaluation of the diagnostic utility for von Willebrand disease of a pediatric bleeding questionnaire.  J Thromb Haemost. 2009;  7 (8) 1418-1421
    Google Scholar
  • 20 Biss T T, Blanchette V S, Clark D S et al.. Quantitation of bleeding symptoms in children with von Willebrand disease: use of a standardized pediatric bleeding questionnaire.  J Thromb Haemost. 2010;  8 (5) 950-956
    Google Scholar
  • 21 Biss T T, Blanchette V S, Clark D S, Wakefield C D, James P D, Rand M L. Use of a quantitative pediatric bleeding questionnaire to assess mucocutaneous bleeding symptoms in children with a platelet function disorder.  J Thromb Haemost. 2010;  8 (6) 1416-1419
    Google Scholar
  • 22 Tosetto A, Castaman G, Rodeghiero F. Bleeding scores in inherited bleeding disorders: clinical or research tools?.  Haemophilia. 2008;  14 (3) 415-422
    Google Scholar
  • 23 Clinical and Laboratory Standards Institute .Platelet Function Testing By Aggregometry; Approved Guideline. 2008 Vol. 28, No. 31
    Google Scholar
  • 24 Cariappa R, Wilhite T R, Parvin C A, Luchtman-Jones L. Comparison of PFA-100 and bleeding time testing in pediatric patients with suspected hemorrhagic problems.  J Pediatr Hematol Oncol. 2003;  25 (6) 474-479
    Google Scholar
  • 25 Schlammadinger A, Kerenyi A, Muszbek L, Boda Z. Comparison of the O'Brien filter test and the PFA-100 platelet analyzer in the laboratory diagnosis of von Willebrand's disease.  Thromb Haemost. 2000;  84 (1) 88-92
    Google Scholar
  • 26 Posan E, McBane R D, Grill D E, Motsko C L, Nichols W L. Comparison of PFA-100 testing and bleeding time for detecting platelet hypofunction and von Willebrand disease in clinical practice.  Thromb Haemost. 2003;  90 (3) 483-490
    Google Scholar
  • 27 Quiroga T, Goycoolea M, Muñoz B et al.. Template bleeding time and PFA-100 have low sensitivity to screen patients with hereditary mucocutaneous hemorrhages: comparative study in 148 patients.  J Thromb Haemost. 2004;  2 (6) 892-898
    Google Scholar
  • 28 Kundu S K, Heilmann E J, Sio R, Garcia C, Davidson R M, Ostgaard R A. Description of an in vitro platelet function analyzer—PFA-100.  Semin Thromb Hemost. 1995;  21 (Suppl 2) 106-112
    Google Scholar
  • 29 Favaloro E J, Facey D, Henniker A. Use of a novel platelet function analyzer (PFA-100) with high sensitivity to disturbances in von Willebrand factor to screen for von Willebrand's disease and other disorders.  Am J Hematol. 1999;  62 (3) 165-174
    Google Scholar
  • 30 Francis J, Francis D, Larson L, Helms E, Garcia M. Can the Platelet Function Analyzer (PFA)-100 test substitute for the template bleeding time in routine clinical practice?.  Platelets. 1999;  10 (2-3) 132-136
    Google Scholar
  • 31 Carcao M D, Blanchette V S, Dean J A et al.. The Platelet Function Analyzer (PFA-100): a novel in-vitro system for evaluation of primary haemostasis in children.  Br J Haematol. 1998;  101 (1) 70-73
    Google Scholar
  • 32 Karger R, Donner-Banzhoff N, Müller H H, Kretschmer V, Hunink M. Diagnostic performance of the platelet function analyzer (PFA-100) for the detection of disorders of primary haemostasis in patients with a bleeding history-a systematic review and meta-analysis.  Platelets. 2007;  18 (4) 249-260
    Google Scholar
  • 33 Hayward C P, Harrison P, Cattaneo M, Ortel T L, Rao A K. Platelet function analyzer (PFA)-100 closure time in the evaluation of platelet disorders and platelet function.  J Thromb Haemost. 2006;  4 312-319
    Google Scholar
  • 34 Kratzer M AA, Kretschmer V. Platelet function analyzer (PFA)-100® closure time in the evaluation of platelet disorders and platelet function—a rebuttal.  J Thromb Haemost. 2006;  4 1429-1431
    Google Scholar
  • 35 Koscielny J, Kiesewetter H, von Tempelhoff G F. More on: platelet function analyzer (PFA)-100 closure time in the evaluation of platelet disorders and platelet function.  J Thromb Haemost. 2006;  4 (6) 1426-1427, discussion 1428–1434
    Google Scholar
  • 36 Varon D, Dardik R, Shenkman B et al.. A new method for quantitative analysis of whole blood platelet interaction with extracellular matrix under flow conditions.  Thromb Res. 1997;  85 (4) 283-294
    Google Scholar
  • 37 Revel-Vilk S, Varon D, Shai E et al.. Evaluation of children with a suspected bleeding disorder applying the Impact-R [Cone And Plate(Let) Analyzer].  J Thromb Haemost. 2009;  7 1990-1996
    Google Scholar
  • 38 Quiroga T, Goycoolea M, Giesen P L et al.. Thrombin generation in platelet-poor plasma is normal in patients with hereditary mucocutaneous haemorrhages.  Pathophysiol Haemost Thromb. 2003;  33 (1) 30-35
    Google Scholar
  • 39 Eugster M, Reinhart W H. The influence of the haematocrit on primary haemostasis in vitro.  Thromb Haemost. 2005;  94 (6) 1213-1218
    Google Scholar
  • 40 Carcao M D, Blanchette V S, Stephens D et al.. Assessment of thrombocytopenic disorders using the Platelet Function Analyzer (PFA-100).  Br J Haematol. 2002;  117 (4) 961-964
    Google Scholar
  • 41 Tosetto A, Castaman G, Rodeghiero F. Evidence-based diagnosis of type 1 von Willebrand disease: a Bayes theorem approach.  Blood. 2008;  111 (8) 3998-4003
    Google Scholar
  • 42 Acharya S S, Coughlin A, Dimichele D M. North American Rare Bleeding Disorder Study Group . Rare Bleeding Disorder Registry: deficiencies of factors II, V, VII, X, XIII, fibrinogen and dysfibrinogenemias.  J Thromb Haemost. 2004;  2 (2) 248-256
    Google Scholar
  • 43 Bernardi F, Dolce A, Pinotti M International Factor VII Deficiency Study Group et al. Major differences in bleeding symptoms between factor VII deficiency and hemophilia B.  J Thromb Haemost. 2009;  7 (5) 774-779
    Google Scholar
  • 44 Plug I, Mauser-Bunschoten E P, Bröcker-Vriends A H et al.. Bleeding in carriers of hemophilia.  Blood. 2006;  108 (1) 52-56
    Google Scholar
  • 45 Hsieh L, Nugent D. Factor XIII deficiency.  Haemophilia. 2008;  14 (6) 1190-1200
    Google Scholar
  • 46 Spreafico M, Peyvandi F. Combined factor V and factor VIII deficiency.  Semin Thromb Hemost. 2009;  35 (4) 390-399
    Google Scholar
  • 47 Nichols W L, Hultin M B, James A H et al.. von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA).  Haemophilia. 2008;  14 (2) 171-232
    Google Scholar
  • 48 Nurden A T, Nurden P. The gray platelet syndrome: clinical spectrum of the disease.  Blood Rev. 2007;  21 (1) 21-36
    Google Scholar
  • 49 Althaus K, Greinacher A. MYH9-related platelet disorders.  Semin Thromb Hemost. 2009;  35 (2) 189-203
    Google Scholar
  • 50 Rao A K. Inherited defects in platelet signaling mechanisms.  J Thromb Haemost. 2003;  1 (4) 671-681
    Google Scholar
  • 51 Bosticardo M, Marangoni F, Aiuti A, Villa A, Grazia Roncarolo M. Recent advances in understanding the pathophysiology of Wiskott-Aldrich syndrome.  Blood. 2009;  113 (25) 6288-6295
    Google Scholar
  • 52 Albert M H, Bittner T C, Nonoyama S et al.. X-linked thrombocytopenia (XLT) due to WAS mutations: clinical characteristics, long-term outcome, and treatment options.  Blood. 2010;  115 (16) 3231-3238
    Google Scholar
  • 53 Owen C. Insights into familial platelet disorder with propensity to myeloid malignancy (FPD/AML).  Leuk Res. 2010;  34 (2) 141-142
    Google Scholar
  • 54 Ballmaier M, Germeshausen M. Advances in the understanding of congenital amegakaryocytic thrombocytopenia.  Br J Haematol. 2009;  146 (1) 3-16
    Google Scholar
  • 55 Geddis A E, Kaushansky K. Inherited thrombocytopenias: toward a molecular understanding of disorders of platelet production.  Curr Opin Pediatr. 2004;  16 (1) 15-22
    Google Scholar
  • 56 Toriello H V. Thrombocytopenia absent radius syndrome. In: Genereviews [Internet]. Seattle, WA: University of Washington; 2009
    Google Scholar
  • 57 Pham A, Wang J. Bernard-Soulier syndrome: an inherited platelet disorder.  Arch Pathol Lab Med. 2007;  131 (12) 1834-1836
    Google Scholar
  • 58 Pallotta R, Evangelista V, Margaglione M, Bucci I, Saponari A. Macrothrombocytopenia in velocardiofacial syndrome.  J Thromb Haemost. 2005;  3 (3) 601-603
    Google Scholar
  • 59 Favaloro E J. Phenotypic identification of platelet-type von Willebrand disease and its discrimination from type 2B von Willebrand disease: a question of 2B or not 2B? A story of nonidentical twins? Or two sides of a multidenominational or multifaceted primary-hemostasis coin?.  Semin Thromb Hemost. 2008;  34 (1) 113-127
    Google Scholar
  • 60 Behrens W E. Mediterranean macrothrombocytopenia.  Blood. 1975;  46 (2) 199-208
    Google Scholar
  • 61 Kacena M A, Kirk J, Chou S T, Weiss M J, Raskind W H. GATA1-related X-linked cytopenia. In: Pagon R A, Bird T D, Dolan C R, Stephens K, eds. GeneReviews [Internet]. University of Washington, Seattle, 2006
    Google Scholar
  • 62 Gunay-Aygun M, Zivony-Elboum Y, Gumruk F et al.. Gray platelet syndrome: natural history of a large patient cohort and locus assignment to chromosome 3p.  Blood. 2010;  116 (23) 4990-5001
    Google Scholar

Shoshana Revel-VilkM.D. M.Sc. 

Department of Pediatric Hematology/Oncology, Hadassah Hebrew University Hospital

POB 12000, Jerusalem 91200, Israel

Email: shoshanav@hadassah.org.il